# Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty

> **NCT01055015** · PHASE3 · COMPLETED · sponsor: **QRxPharma Inc.** · enrollment: 141 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Flexible dose Q8003 (morphine sulfate and oxycodone hydrochloride)
- **DRUG:** Low dose Q8003 (morphine sulfate and oxycodone hydrochloride)

## Key facts

- **NCT ID:** NCT01055015
- **Lead sponsor:** QRxPharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2012-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055015, "Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01055015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*